Related references
Note: Only part of the references are listed.Cinnamon Ameliorates Experimental Allergic Encephalomyelitis in Mice via Regulatory T Cells: Implications for Multiple Sclerosis Therapy
Susanta Mondal et al.
PLOS ONE (2015)
Cinnamon and Its Metabolite Sodium Benzoate Attenuate the Activation of p21rac and Protect Memory and Learning in an Animal Model of Alzheimer's Disease
Khushbu K. Modi et al.
PLOS ONE (2015)
Up-regulation of Ciliary Neurotrophic Factor in Astrocytes by Aspirin IMPLICATIONS FOR REMYELINATION IN MULTIPLE SCLEROSIS
Khushbu K. Modi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Up-Regulation of Neurotrophic Factors by Cinnamon and its Metabolite Sodium Benzoate: Therapeutic Implications for Neurodegenerative Disorders
Arundhati Jana et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2013)
Gemfibrozil and Fenofibrate, Food and Drug Administration-approved Lipid-lowering Drugs, Up-regulate Tripeptidyl-peptidase 1 in Brain Cells via Peroxisome Proliferator-activated Receptor α IMPLICATIONS FOR LATE INFANTILE BATTEN DISEASE THERAPY
Arunava Ghosh et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Gemfibrozil, a Lipid-lowering Drug, Increases Myelin Genes in Human Oligodendrocytes via Peroxisome Proliferator-activated Receptor-β
Malabendu Jana et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Suppression of Nuclear Factor-κB Activation and Inflammation in Microglia by Physically Modified Saline
Saurabh Khasnavis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Gemfibrozil, a Lipid-lowering Drug, Induces Suppressor of Cytokine Signaling 3 in Glial Cells IMPLICATIONS FOR NEURODEGENERATIVE DISORDERS
Arunava Ghosh et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Gemfibrozil, a Lipid-Lowering Drug, Upregulates IL-1 Receptor Antagonist in Mouse Cortical Neurons: Implications for Neuronal Self-Defense
Grant T. Corbett et al.
JOURNAL OF IMMUNOLOGY (2012)
Sodium Benzoate, a Metabolite of Cinnamon and a Food Additive, Upregulates Neuroprotective Parkinson Disease Protein DJ-1 in Astrocytes and Neurons
Saurabh Khasnavis et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2012)
The molecular biology of memory: cAMP, PKA, CRE, CREB-1, CREB-2, and CPEB
Eric R. Kandel
MOLECULAR BRAIN (2012)
Neuroimmune Pharmacological Control of EAE
Kalipada Pahan
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2010)
Fibrillar Amyloid-β-Activated Human Astroglia Kill Primary Human Neurons via Neutral Sphingomyelinase: Implications for Alzheimer's Disease
Arundhati Jana et al.
JOURNAL OF NEUROSCIENCE (2010)
Sodium Benzoate, a Metabolite of Cinnamon and a Food Additive, Reduces Microglial and Astroglial Inflammatory Responses
Saurav Brahmachari et al.
JOURNAL OF IMMUNOLOGY (2009)
Overexpression of CNTF in Mesenchymal Stem Cells reduces demyelination and induces clinical recovery in experimental autoimmune encephalomyelitis mice
Zhengqi Lu et al.
JOURNAL OF NEUROIMMUNOLOGY (2009)
Proteome Profiling in Murine Models of Multiple Sclerosis: Identification of Stage Specific Markers and Culprits for Tissue Damage
Ralf A. Linker et al.
PLOS ONE (2009)
Signaling through cAMP and cAMP-dependent protein kinase: Diverse strategies for drug design
Susan S. Taylor et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2008)
A simplified method for isolating highly purified neurons, oligodendrocytes, astrocytes, and microglia from the same human fetal brain tissue
Malabendu Jana et al.
NEUROCHEMICAL RESEARCH (2007)
Neurological implications of urea cycle disorders
A. L. Gropman et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2007)
Sodium benzoate, a food additive and a metabolite of cinnamon, modifies T cells at multiple steps and inhibits adoptive transfer of experimental allergic encephalomyelitis
Saurav Brahmachari et al.
JOURNAL OF IMMUNOLOGY (2007)
Continued administration of ciliary neurotrophic factor protects mice from inflammatory pathology in experimental autoimmune encephalomyelitis
Tanja Kuhlmann et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Sox10 regulates ciliary neurotrophic factor gene expression in Schwann cells
Yasuhiro Ito et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Induction of glial fibrillary acidic protein expression in astrocytes by nitric oxide
S Brahmachari et al.
JOURNAL OF NEUROSCIENCE (2006)
Intracompartmental delivery of CNTF as therapy for Huntingtons disease and retinitis pigmentosa
DF Emerich et al.
CURRENT GENE THERAPY (2006)
Effect of alternative pathway therapy on branched chain amino acid metabolism in urea cycle disorder patients
F Scaglia et al.
MOLECULAR GENETICS AND METABOLISM (2004)
Signaling from cAMP/PKA to MAPK and synaptic plasticity
R Waltereit et al.
MOLECULAR NEUROBIOLOGY (2003)
CNTF is a major protective factor in demyelinating CNS disease:: A neurotrophic cytokine as modulator in neuroinflammation
RA Linker et al.
NATURE MEDICINE (2002)
Association of a null mutation in the CNTF gene with early onset of multiple sclerosis
R Giess et al.
ARCHIVES OF NEUROLOGY (2002)
Share Paper
